Cargando…
Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis
BACKGROUND: Diabetes ketoacidosis (DKA) is a life-threatening complication of type 1 diabetes mellitus (T1DM). Reducing DKA admissions in children with T1DM requires a coordinated, comprehensive management plan. We aimed to decrease DKA admissions, 30-day readmissions, and length of stay (LOS) for D...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054972/ https://www.ncbi.nlm.nih.gov/pubmed/27749721 http://dx.doi.org/10.1097/QMH.0000000000000109 |
_version_ | 1782458699206361088 |
---|---|
author | Ilkowitz, Jeniece Trast Choi, Steven Rinke, Michael L. Vandervoot, Kathy Heptulla, Rubina A. |
author_facet | Ilkowitz, Jeniece Trast Choi, Steven Rinke, Michael L. Vandervoot, Kathy Heptulla, Rubina A. |
author_sort | Ilkowitz, Jeniece Trast |
collection | PubMed |
description | BACKGROUND: Diabetes ketoacidosis (DKA) is a life-threatening complication of type 1 diabetes mellitus (T1DM). Reducing DKA admissions in children with T1DM requires a coordinated, comprehensive management plan. We aimed to decrease DKA admissions, 30-day readmissions, and length of stay (LOS) for DKA admissions. METHODS: A multipronged intervention was designed in 2011 to reach all patients: (1) increase insulin pump use and basal-bolus regimen versus sliding scales, (2) transform educational program, (3) increased access to medical providers, and (4) support for patients and families. A before-after study was conducted comparing performance outcomes in years 2007-2010 (preintervention) to 2012-2014 (postintervention) using administrative data and Wilcoxon rank sum and Fischer exact tests. RESULTS: DKA admissions decreased by 44% postintervention (16.7 vs 9.3 per 100 followed patient-years; P = .006), unique patient 30-day readmissions decreased from 20% to 5% postintervention (P = .001), and median LOS significantly decreased postintervention (P < .0001). Although not an original goal of the study, median hemoglobin A1C of a subset of the population transitioned from sliding scale decreased, 10.3% to 8.9% (P < .02). CONCLUSIONS: When clinical and widespread program interventions were used, significant reductions in DKA hospitalizations, 30-day readmissions, and LOS occurred for pediatric T1DM. Continuous performance improvement efforts are needed for improving DKA outcomes. |
format | Online Article Text |
id | pubmed-5054972 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Wolters Kluwer Health, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-50549722016-11-01 Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis Ilkowitz, Jeniece Trast Choi, Steven Rinke, Michael L. Vandervoot, Kathy Heptulla, Rubina A. Qual Manag Health Care Quality Improvement BACKGROUND: Diabetes ketoacidosis (DKA) is a life-threatening complication of type 1 diabetes mellitus (T1DM). Reducing DKA admissions in children with T1DM requires a coordinated, comprehensive management plan. We aimed to decrease DKA admissions, 30-day readmissions, and length of stay (LOS) for DKA admissions. METHODS: A multipronged intervention was designed in 2011 to reach all patients: (1) increase insulin pump use and basal-bolus regimen versus sliding scales, (2) transform educational program, (3) increased access to medical providers, and (4) support for patients and families. A before-after study was conducted comparing performance outcomes in years 2007-2010 (preintervention) to 2012-2014 (postintervention) using administrative data and Wilcoxon rank sum and Fischer exact tests. RESULTS: DKA admissions decreased by 44% postintervention (16.7 vs 9.3 per 100 followed patient-years; P = .006), unique patient 30-day readmissions decreased from 20% to 5% postintervention (P = .001), and median LOS significantly decreased postintervention (P < .0001). Although not an original goal of the study, median hemoglobin A1C of a subset of the population transitioned from sliding scale decreased, 10.3% to 8.9% (P < .02). CONCLUSIONS: When clinical and widespread program interventions were used, significant reductions in DKA hospitalizations, 30-day readmissions, and LOS occurred for pediatric T1DM. Continuous performance improvement efforts are needed for improving DKA outcomes. Wolters Kluwer Health, Inc. 2016-10 2016-10-14 /pmc/articles/PMC5054972/ /pubmed/27749721 http://dx.doi.org/10.1097/QMH.0000000000000109 Text en © 2016 Wolters Kluwer Health, Inc. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially. |
spellingShingle | Quality Improvement Ilkowitz, Jeniece Trast Choi, Steven Rinke, Michael L. Vandervoot, Kathy Heptulla, Rubina A. Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis |
title | Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis |
title_full | Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis |
title_fullStr | Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis |
title_full_unstemmed | Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis |
title_short | Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis |
title_sort | pediatric type 1 diabetes: reducing admission rates for diabetes ketoacidosis |
topic | Quality Improvement |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054972/ https://www.ncbi.nlm.nih.gov/pubmed/27749721 http://dx.doi.org/10.1097/QMH.0000000000000109 |
work_keys_str_mv | AT ilkowitzjeniecetrast pediatrictype1diabetesreducingadmissionratesfordiabetesketoacidosis AT choisteven pediatrictype1diabetesreducingadmissionratesfordiabetesketoacidosis AT rinkemichaell pediatrictype1diabetesreducingadmissionratesfordiabetesketoacidosis AT vandervootkathy pediatrictype1diabetesreducingadmissionratesfordiabetesketoacidosis AT heptullarubinaa pediatrictype1diabetesreducingadmissionratesfordiabetesketoacidosis |